Effect of Mucolytic in treatment of cystic fibrosis
Phase 2
- Conditions
- Cystic fibrosis.Cystic fibrosis with pulmonary manifestations
- Registration Number
- IRCT20180307038994N1
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Patients with cystic fibrosis older than 5 years
Ability to perform spirometery
Exclusion Criteria
Age less than 5 years
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pulmonary function based on spirometry. Timepoint: Spirometry at the beginning of study and at the end of study after two weeks of treatment. Method of measurement: Spirometry device.
- Secondary Outcome Measures
Name Time Method